Intellectual Property

The Human BioMolecular Research Institute (HBRI) has filed the following patents with the United States Patent and Trademark Office. For further information or for inquiries into licensing intellectual property at HBRI please contact the Director, HBRI, 5310 Eastgate Mall, San Diego, CA 92121; Telephone (858) 458-9305; Fax: (858) 458-9311 or email: JCashman@hbri.org.



Patents

Title: Synthetic compounds and derivatives as modulators of central nervous system neurotransmitters.

Title: cDNA encoding a novel esterase: Development of a better cocaine detoxication catalyst useful in central nervous system and peripheral diseases.

Human BioMolecular Research Institute Technology Transfer.

HBRI partners with for-profit and non-profit groups to help promote research and develop products from intellectual property discovered and developed at the Institute.

Bringing scientific discoveries to collaborators and developing research partners in the for-profit sector is an end-product of research done at the Institute. While the goal of HBRI is not to develop products to sell, HBRI encourages collaborations and partnerships with other groups that have an interest in developing intellectual property discovered at the HBRI for the good of society. For more information contact the scientists involved in the discovery or contact the Director indicated at left.